Jesse Robert Rickelman is a pharmacist who is specialized in Nuclear in Highland, Indiana. Patients can reach him at 2715 Main St, Highland or contact him on 219-924-3795. Active license number of Jesse Robert Rickelman is 26023662A for Nuclear in Indiana. Jesse Robert Rickelman is a licensed pharmacist who has demonstrated specialized knowledge and skill in procurement, compounding, quality control testing, dispensing, distribution, and monitoring of radiopharmaceuticals.
Complete Profile:
Jesse Robert Rickelman speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Jesse Robert Rickelman
Specialization:
Nuclear
Credentials:
PHARMD.
Gender:
Male
Location:
2715 Main St, Highland, Indiana, 46322-3636
Phone:
219-924-3795
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Jesse Robert Rickelman are as mentioned below.
NPI Number:
1154854289
NPI Enumeration Date:
05 Apr, 2017
NPI Last Update On:
05 Apr, 2017
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Jesse Robert Rickelman are as mentioned below.
Specialization
License Number
State
Status
Nuclear
26023662A
Indiana
Primary
Nuclear
5637
South Dakota
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2708 43rd St, Highland, Indiana
Zip:
46322-3062
Phone Number:
630-651-1952
Fax Number:
--
Patients can reach Jesse Robert Rickelman at 2715 Main St, Highland, Indiana or can call on phone at 219-924-3795.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.